JINYU

Wallstreetcn · Apr 14 at 05:38 PM

South African Serotype 1 Foot-and-Mouth Disease Disrupts Livestock Industry Chain

Zhitong · Oct 28, 2025 at 01:15 AM

Huachuang Securities: In the first three quarters, most vaccine varieties saw year-on-year growth in batch approvals, and pet vaccines continued to maintain a high growth rate

Zhitong · Oct 27, 2025 at 03:03 AM

JINYU released its performance for the first three quarters, with a net profit attributable to the parent company of 161 million yuan, a decrease of 4.85%

Zhitong · Oct 27, 2025 at 02:44 AM

JINYU: Plans to repurchase and cancel 120,000 shares of stock

Zhitong · Oct 16, 2025 at 03:13 AM

JINYU: The gene-engineered subunit vaccine for bovine gas gangrene (Type A) has obtained a new veterinary drug registration certificate

Zhitong · Sep 30, 2025 at 03:03 AM

Huachuang Securities: In August, the growth of vaccines for diarrhea, brucellosis, and feline trivalent was strong, and the raw materials for veterinary drugs are entering a peak season with price increases